Loading stock data…
QSI
$0.96-0.02 (-2.28%)
Market ClosedLast close May 1
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS).
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quantum-Si incorporated in the Healthcare sector is trading at $0.96. The stock is currently near its 52-week low of $0.69, remaining 26.3% below its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why QSI maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.96
Potential Upside
5%
Whystock Fair Value$1.01
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instrument...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$229.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.09
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-46.02%
Volume
Today's trading volume
3.56M
Recent News
Quantum-Si incorporated Q4 2025 Earnings Call Summary
Moby summary of Quantum-Si incorporated's Q4 2025 earnings call
Quantum-Si Inc (QSI) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges
Quantum-Si Inc (QSI) showcases technological progress and strategic planning despite facing revenue and profitability pressures.
Quantum-Si (QSI) Q4 2025 Earnings Call Transcript
Joining me today are Jeffrey Hawkins, our President and Chief Executive Officer, as well as Jeffry R. Keyes, our Chief Financial Officer. As a reminder, during 2025, we announced the launch of an expanded set of instrument acquisition options that allow customers to have our instrument in their lab and purchase and run consumables without having to find the capital dollars to acquire the instrument upfront.
Quantum-Si Q4 Earnings Call Highlights
Quantum-Si (NASDAQ:QSI) reported fourth-quarter and full-year 2025 results and outlined a “transition year” outlook for 2026, as management said it plans to prioritize development and commercial readiness for the Proteus platform ahead of an expected launch at the end of 2026. 2026 positioned as a
Quantum-Si (NASDAQ:QSI) shareholders have endured a 89% loss from investing in the stock five years ago
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...